Literature DB >> 24366974

Getting more out of radiation therapy in glioblastoma.

Brandyn A Castro1, Manish K Aghi.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2014        PMID： 24366974      PMCID： PMC3870825          DOI： 10.1093/neuonc/not233

Source DB:  PubMed          Journal:  Neuro Oncol        ISSN： 1522-8517            Impact factor:   12.300


× No keyword cloud information.
  16 in total

1.  Inhibition of vasculogenesis, but not angiogenesis, prevents the recurrence of glioblastoma after irradiation in mice.

Authors:  Mitomu Kioi; Hannes Vogel; Geoffrey Schultz; Robert M Hoffman; Griffith R Harsh; J Martin Brown
Journal:  J Clin Invest       Date:  2010-02-22       Impact factor: 14.808

2.  The chemokine SDF-1/CXCL12 binds to and signals through the orphan receptor RDC1 in T lymphocytes.

Authors:  Karl Balabanian; Bernard Lagane; Simona Infantino; Ken Y C Chow; Julie Harriague; Barbara Moepps; Fernando Arenzana-Seisdedos; Marcus Thelen; Françoise Bachelerie
Journal:  J Biol Chem       Date:  2005-08-17       Impact factor: 5.157

3.  AMD3100 is a CXCR7 ligand with allosteric agonist properties.

Authors:  Irina Kalatskaya; Yamina A Berchiche; Stéphanie Gravel; Brian J Limberg; Jan S Rosenbaum; Nikolaus Heveker
Journal:  Mol Pharmacol       Date:  2009-03-02       Impact factor: 4.436

4.  Contribution of bone marrow-derived endothelial cells to human tumor vasculature.

Authors:  Brock A Peters; Luis A Diaz; Kornelia Polyak; Leslie Meszler; Kathy Romans; Eva C Guinan; Joseph H Antin; David Myerson; Stanley R Hamilton; Bert Vogelstein; Kenneth W Kinzler; Christoph Lengauer
Journal:  Nat Med       Date:  2005-02-20       Impact factor: 53.440

5.  Patient tumor EGFR and PDGFRA gene amplifications retained in an invasive intracranial xenograft model of glioblastoma multiforme.

Authors:  Caterina Giannini; Jann N Sarkaria; Atsushi Saito; Joon H Uhm; Evanthia Galanis; Brett L Carlson; Mark A Schroeder; C David James
Journal:  Neuro Oncol       Date:  2005-04       Impact factor: 12.300

6.  Tumor stromal-derived factor-1 recruits vascular progenitors to mitotic neovasculature, where microenvironment influences their differentiated phenotypes.

Authors:  Manish Aghi; Kenneth S Cohen; Rachael J Klein; David T Scadden; E Antonio Chiocca
Journal:  Cancer Res       Date:  2006-09-15       Impact factor: 12.701

7.  Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma.

Authors:  Roger Stupp; Warren P Mason; Martin J van den Bent; Michael Weller; Barbara Fisher; Martin J B Taphoorn; Karl Belanger; Alba A Brandes; Christine Marosi; Ulrich Bogdahn; Jürgen Curschmann; Robert C Janzer; Samuel K Ludwin; Thierry Gorlia; Anouk Allgeier; Denis Lacombe; J Gregory Cairncross; Elizabeth Eisenhauer; René O Mirimanoff
Journal:  N Engl J Med       Date:  2005-03-10       Impact factor: 91.245

8.  Beta-arrestin- but not G protein-mediated signaling by the "decoy" receptor CXCR7.

Authors:  Sudarshan Rajagopal; Jihee Kim; Seungkirl Ahn; Stewart Craig; Christopher M Lam; Norma P Gerard; Craig Gerard; Robert J Lefkowitz
Journal:  Proc Natl Acad Sci U S A       Date:  2009-12-17       Impact factor: 11.205

9.  Direct evidence that bevacizumab, an anti-VEGF antibody, up-regulates SDF1alpha, CXCR4, CXCL6, and neuropilin 1 in tumors from patients with rectal cancer.

Authors:  Lei Xu; Dan G Duda; Emmanuelle di Tomaso; Marek Ancukiewicz; Daniel C Chung; Gregory Y Lauwers; Rekha Samuel; Paul Shellito; Brian G Czito; Pei-Chun Lin; Martin Poleski; Rex Bentley; Jeffrey W Clark; Christopher G Willett; Rakesh K Jain
Journal:  Cancer Res       Date:  2009-10-13       Impact factor: 12.701

10.  Blockade of SDF-1 after irradiation inhibits tumor recurrences of autochthonous brain tumors in rats.

Authors:  Shie-Chau Liu; Reem Alomran; Sophia B Chernikova; Fred Lartey; Jason Stafford; Taichang Jang; Milton Merchant; Dirk Zboralski; Stefan Zöllner; Anna Kruschinski; Sven Klussmann; Lawrence Recht; J Martin Brown
Journal:  Neuro Oncol       Date:  2013-12-10       Impact factor: 12.300
View more
  1 in total

1.  Feasibility of intratumoral 165Holmium siloxane delivery to induced U87 glioblastoma in a large animal model, the Yucatan minipig.

Authors:  Mehrdad Khoshnevis; Claude Carozzo; Richard Brown; Manuel Bardiès; Catherine Bonnefont-Rebeix; Sara Belluco; Christophe Nennig; Lionel Marcon; Olivier Tillement; Hélène Gehan; Cédric Louis; Ilyes Zahi; Thierry Buronfosse; Thierry Roger; Frédérique Ponce
Journal:  PLoS One       Date:  2020-06-18       Impact factor: 3.240
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.